GHRL and cancer: With a combined sample size of 22,438 (8,430 cases and 14,008 controls), this meta-analysis provides evidence of overall homozygous and recessive associations, indicating a ~2-fold non-significant increase in cancer risk for the GHRL SNP rs4684677 and a ~1.4-fold non-significant increased risk for the GHSR SNP rs572169.